Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma of the Gastroesophageal Junction

Explore clinical trials studying Adenocarcinoma of the Gastroesophageal Junction. Study availability and eligibility vary by location and protocol.

36 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma of the Gastroesophageal Junction trial results

Completed

A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab

NCT02013154

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Carcinoma, Carcinoma, Squamous Cell, +15 more
Locations
  • Cedars Sinai Medical Care Foundation Los Angeles, California, United States
  • Smilow Cancer Hospital at Yale - New Haven New Haven, Connecticut, United States
  • Northwestern University Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

NCT02443324

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Biliary Tract Cancer, Biliary Tract Diseases, +32 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Cancer Specialists and Research Institute St. Petersburg, Florida, United States
  • Tennessee Oncology PLLC Chattanooga, Tennessee, United States
View all 22 locations
View Trial Details
Completed

Perioperative Chemo and Pembrolizumab in Gastric Cancer

NCT02918162

Conditions
Adenocarcinoma, Adenocarcinoma of the Gastroesophageal Junction, Carcinoma, +11 more
Locations
  • Haesong Park St Louis, Missouri, United States
  • Weill Cornell Medical College/ NewYork-Presbyterian New York, United States
  • Columbia University Medical Center New York, United States
  • Brown University Providence, Rhode Island, United States
View Trial Details
Completed

PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy

NCT01333033

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Digestive System Diseases, +9 more
Locations
  • Camino Medical Group - Treatment Center Mountain View, California, United States
  • Palo Alto Medical Foundation Palo Alto, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 68 locations
View Trial Details
Completed

Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer

NCT01212822

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, +35 more
Locations
  • Case Western Reserve University Cleveland, Ohio, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

NCT01107639

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Carcinoma, +15 more
Locations
  • Landeskrankenhaus Feldkirch, Austria
  • Universitätsklinik für Innere Medizin I Innsbruck, Austria
  • Krankenhaus Barmherzige Schwestern Linz Linz, Austria
  • Krankenhaus der Elisabethinen Linz GmbH Linz, Austria
View all 57 locations
View Trial Details
Completed

S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer

NCT01498289

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Digestive System Diseases, +12 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Sutter Auburn Faith Hospital Auburn, California, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
View all 508 locations
View Trial Details

Related conditions